Breast Cancer Survivors at Risk
Researchers at the Heart Research Institute are developing a drug to protect breast cancer survivors from heart disease caused by chemotherapy, as 30% of survivors face serious cardiovascular complications. Using lab-grown “mini hearts,” they aim to identify at-risk patients and provide therapies that safeguard heart health during cancer treatment.
